Evidence map›Paper›PMID 34602502›Full record

ArticleJournal of Parkinson's disease2022

Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables.

Ibrahim Karabayir, Liam Butler, Samuel M Goldman, Rishikesan Kamaleswaran, Fatma Gunturkun, Robert L Davis, G Webster Ross, Helen Petrovitch, Kamal Masaki, Caroline M Tanner and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Principles of Artificial Intellgence for Medicine.Journal of the American Heart Association · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Ibrahim KarabayirLoyola University Chicago, Maywood, IL, USA.
Liam ButlerLoyola University Chicago, Maywood, IL, USA.
Samuel M GoldmanUniversity of California San Francisco, San Francisco, CA, USA.
Rishikesan KamaleswaranEmory University, Atlanta, GA, USA.
Fatma GunturkunUniversity of Tennessee Health Sciences Center, Memphis,, TN, USA.
Robert L DavisUniversity of Tennessee Health Sciences Center, Memphis,, TN, USA.
G Webster RossVeterans Affairs Pacific Islands Health Care System, Honolulu, HI, USA.
Helen PetrovitchVeterans Affairs Pacific Islands Health Care System, Honolulu, HI, USA.
Kamal MasakiDepartment of Geriatric Medicine, University of Hawaii, Honolulu, HI, USA.
Caroline M TannerUniversity of California San Francisco, San Francisco, CA, USA.
Georgios TsivgoulisUniversity of Tennessee Health Sciences Center, Memphis,, TN, USA.
Andrei V AlexandrovUniversity of Tennessee Health Sciences Center, Memphis,, TN, USA.
Lokesh K ChinthalaUniversity of Tennessee Health Sciences Center, Memphis,, TN, USA.
Oguz AkbilgicWake Forest School of Medicine, Winston-Salem, NC, USA.
University of Tennessee Health Science Center · USLoyola University Chicago · USUniversity of California, San Francisco · USUniversity of Hawaii System · USGeorgia Institute of Technology · USKuakini Medical Center · USWake Forest University · US

Funding

Targeted Research Training CoreT42OH008429 · OH · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARRIS ADAMSON, CARISA · 2005 to 2024
$30.0M
NIOSH CDC HHS T42 OH008429
6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is a chronic, disabling neurodegenerative disorder.

objectiveTo predict a future diagnosis of PD using questionnaires and simple non-invasive clinical tests.

methodsParticipants in the prospective Kuakini Honolulu-Asia Aging Study (HAAS) were evaluated biannually between 1995-2017 by PD experts using standard diagnostic criteria. Autopsies were sought on all deaths. We input simple clinical and risk factor variables into an ensemble-tree based machine learning algorithm and derived models to predict the probability of developing PD. We also investigated relationships of predictive models and neuropathologic features such as nigral neuron density.

resultsThe study sample included 292 subjects, 25 of whom developed PD within 3 years and 41 by 5 years. 116 (46%) of 251 subjects not diagnosed with PD underwent autopsy. Light Gradient Boosting Machine modeling of 12 predictors correctly classified a high proportion of individuals who developed PD within 3 years (area under the curve (AUC) 0.82, 95%CI 0.76-0.89) or 5 years (AUC 0.77, 95%CI 0.71-0.84). A large proportion of controls who were misclassified as PD had Lewy pathology at autopsy, including 79%of those who died within 3 years. PD probability estimates correlated inversely with nigral neuron density and were strongest in autopsies conducted within 3 years of index date (r = -0.57, p < 0.01).

conclusionMachine learning can identify persons likely to develop PD during the prodromal period using questionnaires and simple non-invasive tests. Correlation with neuropathology suggests that true model accuracy may be considerably higher than estimates based solely on clinical diagnosis.

Indexed as

Parkinson DiseaseHumansMachine LearningProdromal SymptomsProspective StudiesRisk FactorsLewy body pathologymachine learningneuron densityParkinson’s disease

Identifiers

PMID34602502
PMCPMC8842767
OpenAlexW3202393678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.